Generic Name
thiotepa
Drug Description
One vial contains 100 mg thiotepa. After reconstitution with 10 ml of water for injection, each ml of solution contains 10 mg thiotepa (10 mg/ml)
Presentation
Powder for concentrate for solution for infusion.White crystalline powder
Indications
TEPADINA is indicated, in combination with other chemotherapy medicinal products: 1) with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients;2) when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients
Adult Dosage
TEPADINA administration must be supervised by a physician experienced in conditioning treatment prior to haematopoietic progenitor cell transplantation.
TEPADINA is administered at different doses, in combination with other chemotherapeutic medicinal products, in patients with haematological diseases or solid tumours prior to HPCT.
TEPADINA posology is reported, in adult and paediatric patients, according to the type of HPCT (autologous or allogeneic) and disease.
Posology
